Reshma Kewalramani - 16 Sep 2021 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Director
Signature
/s/ Karen Tepichin, Attorney-in-fact
Issuer symbol
DNA
Transactions as of
16 Sep 2021
Net transactions value
$0
Form type
4
Filing time
20 Sep 2021, 21:51:13 UTC
Previous filing
23 Aug 2021
Next filing
23 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Stock Option Award $0 +51,782 $0.000000 51,782 16 Sep 2021 Class A Common Stock 51,782 $11.42 Direct F1
transaction DNA Stock Option Award $0 +17,649 $0.000000 17,649 16 Sep 2021 Class A Common Stock 17,649 $11.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in three substantially equal annual installments beginning on September 16, 2022.
F2 The stock option vests on the earlier of either September 16, 2022 or the day before the Issuer's next annual meeting of stockholders.